/
Elanco Animal Health Incorporated and its subsidiaries (collectively, Elanco, the Company, we, us, or our) is a global leader in animal health, dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. We partner with farmers, pet owners, veterinarians and society to create value and help our customers improve the health of animals in th…
16.86% operating margin is respectable but not wide. ROIC at 7.39%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 6.2%, steady but not accelerating. Free cash flow declined 28% despite revenue growth, conversion is weakening.
Free cash flow declined 28% versus the prior year, cash generation momentum has weakened. Net debt of $3.67B represents 12.9x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
$4.89B
▲ +6.2% YoY
Net Income (TTM)
-$242M
▼ -168.6% YoY
Op. Margin
17.43%
▲ +5.9pp YoY
ROIC
7.48%
▲ +4.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$315M
▼ -27.9% YoY
Op. Cash Flow (TTM)
$577M
▲ +3.5% YoY
Net Debt
$3.64B
Cash & Equiv.
$428M
5Y CAGR: +7.6%
Continue Research